Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab. One-year outcome in the EPILOG trial

A. Michael Lincoff, James E. Tcheng, Robert M. Califf, Dean J. Kereiakes, Thomas A. Kelly, Gerald C. Timmis, Neal S. Kleiman, Joan E. Booth, Craig Balog, Catherine F. Cabot, Keaven M. Anderson, Harlan F. Weisman, Eric J. Topol

Research output: Contribution to journal › Article › peer-review

158 Scopus citations

Fingerprint

Dive into the research topics of 'Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab. One-year outcome in the EPILOG trial'. Together they form a unique fingerprint.

Medicine & Life Sciences